Share-based Payment Arrangement, Expense in USD of LIFECORE BIOMEDICAL, INC. \DE\ from Q3 2011 to 2024

Taxonomy & unit
us-gaap: USD
Description
Amount of expense for award under share-based payment arrangement. Excludes amount capitalized.
Summary
LIFECORE BIOMEDICAL, INC. \DE\ quarterly/annual Share-based Payment Arrangement, Expense history and change rate from Q3 2011 to 2024.
  • LIFECORE BIOMEDICAL, INC. \DE\ Share-based Payment Arrangement, Expense for the quarter ending 24 Nov 2024 was $3.37M, a 114% increase year-over-year.
  • LIFECORE BIOMEDICAL, INC. \DE\ Share-based Payment Arrangement, Expense for the twelve months ending 24 Nov 2024 was $8.88M, a 84.1% increase year-over-year.
  • LIFECORE BIOMEDICAL, INC. \DE\ annual Share-based Payment Arrangement, Expense for 2024 was $10.2M, a 63.8% increase from 2023.
  • LIFECORE BIOMEDICAL, INC. \DE\ annual Share-based Payment Arrangement, Expense for 2023 was $6.2M, a 71.7% increase from 2022.
  • LIFECORE BIOMEDICAL, INC. \DE\ annual Share-based Payment Arrangement, Expense for 2022 was $3.61M, a 38.5% increase from 2021.
Share-based Payment Arrangement, Expense, Trailing 12 Months (USD)
Share-based Payment Arrangement, Expense, Quarterly (USD)
Share-based Payment Arrangement, Expense, YoY Quarterly Change (%)
Share-based Payment Arrangement, Expense, Annual (USD)
Share-based Payment Arrangement, Expense, YoY Annual Change (%)

LIFECORE BIOMEDICAL, INC. \DE\ Quarterly Share-based Payment Arrangement, Expense (USD)

Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q4 2024 $8.88M $3.37M +$1.8M +114% 26 Aug 2024 24 Nov 2024 10-Q 02 Jan 2025
Q3 2024 $7.09M $2.42M +$886K +57.8% 27 May 2024 25 Aug 2024 10-Q 04 Oct 2024
Q2 2024 $6.2M $1.6M +$785K +96.7% 26 Feb 2024 26 May 2024 10-K 07 Aug 2025
Q1 2024 $5.42M $1.49M +$591K +65.4% 27 Nov 2023 25 Feb 2024 10-Q 09 Aug 2024
Q4 2023 $4.83M $1.58M +$465K +41.8% 28 Aug 2023 26 Nov 2023 10-Q 02 Jan 2025
Q3 2023 $4.36M $1.53M +$748K +95.3% 29 May 2023 27 Aug 2023 10-Q 04 Oct 2024
Q2 2023 $3.61M $812K +$132K +19.4% 27 Feb 2023 28 May 2023 10-K 26 Aug 2024
Q1 2023 $3.48M $903K +$281K +45.2% 28 Nov 2022 26 Feb 2023 10-Q 09 Aug 2024
Q4 2022 $3.2M $1.11M +$426K +62.1% 29 Aug 2022 27 Nov 2022 10-Q 09 Aug 2024
Q3 2022 $2.77M $785K +$165K +26.6% 30 May 2022 28 Aug 2022 10-Q 09 Aug 2024
Q2 2022 $2.61M $680K -$99K -12.7% 28 Feb 2022 29 May 2022 10-K 26 Aug 2024
Q1 2022 $2.71M $622K -$175K -22% 29 Nov 2021 27 Feb 2022 10-Q 02 Jun 2023
Q4 2021 $2.88M $686K -$206K -23.1% 30 Aug 2021 28 Nov 2021 10-Q 16 Mar 2023
Q3 2021 $3.09M $620K -$272K -30.5% 31 May 2021 29 Aug 2021 10-Q/A 16 Mar 2023
Q2 2021 $3.36M $779K +$241K +44.8% 01 Mar 2021 30 May 2021 10-K 20 Mar 2024
Q1 2021 $3.12M $797K +$231K +40.8% 30 Nov 2020 28 Feb 2021 10-Q 07 Apr 2022
Q4 2020 $2.89M $892K +$105K +13.3% 31 Aug 2020 29 Nov 2020 10-Q 07 Jan 2022
Q3 2020 $2.78M $892K +$364K +68.9% 01 Jun 2020 30 Aug 2020 10-Q 05 Oct 2021
Q2 2020 $2.42M $538K -$540K -50.1% 24 Feb 2020 31 May 2020 10-K/A 16 Mar 2023
Q1 2020 $2.96M $566K -$250K -30.6% 25 Nov 2019 23 Feb 2020 10-Q 08 Apr 2021
Q4 2019 $3.21M $787K -$151K -16.1% 26 Aug 2019 24 Nov 2019 10-Q 07 Jan 2021
Q3 2019 $3.36M $528K -$200K -27.5% 27 May 2019 25 Aug 2019 10-Q 07 Oct 2020
Q2 2019 $3.56M $1.08M -$112K -9.41% 25 Feb 2019 26 May 2019 10-K 29 Jul 2021
Q1 2019 $3.67M $816K -$331K -28.9% 26 Nov 2018 24 Feb 2019 10-Q 03 Apr 2020
Q4 2018 $4M $938K -$178K -16% 27 Aug 2018 25 Nov 2018 10-Q 02 Jan 2020
Q3 2018 $4.18M $728K -$222K -23.4% 28 May 2018 26 Aug 2018 10-Q 03 Oct 2019
Q2 2018 $4.4M $1.19M +$68K +6.06% 26 Feb 2018 27 May 2018 10-K 14 Aug 2020
Q1 2018 $4.34M $1.15M +$78K +7.3% 27 Nov 2017 25 Feb 2018 10-Q 04 Apr 2019
Q4 2017 $4.26M $1.12M +$150K +15.5% 28 Aug 2017 26 Nov 2017 10-Q 07 Jan 2019
Q3 2017 $4.11M $950K +$143K +17.7% 29 May 2017 27 Aug 2017 10-Q 05 Oct 2018
Q2 2017 $3.96M $1.12M +$238K +26.9% 27 Feb 2017 28 May 2017 10-K 01 Aug 2019
Q1 2017 $3.73M $1.07M +$185K +20.9% 28 Nov 2016 26 Feb 2017 10-Q 05 Apr 2018
Q4 2016 $3.54M $966K +$66K +7.33% 29 Aug 2016 27 Nov 2016 10-Q 05 Jan 2018
Q3 2016 $3.48M $807K +$10K +1.26% 30 May 2016 28 Aug 2016 10-Q 28 Sep 2017
Q2 2016 $3.47M $884K +$350M 29 Feb 2016 29 May 2016 10-K 09 Aug 2018
Q1 2016 -$347M $884K +$493K +126% 29 Nov 2015 28 Feb 2016 10-Q 07 Apr 2017
Q4 2015 -$347M $900K -$349M -99.7% 31 Aug 2015 29 Nov 2015 10-Q 05 Jan 2017
Q3 2015 $1.98M $797K +$399K +100% 01 Jun 2015 30 Aug 2015 10-Q 29 Sep 2016
Q2 2015 $1.58M -$349M +$364M +51% 02 Mar 2015 31 May 2015 10-K/A 15 Mar 2018
Q1 2015 -$362M $391K -$353M -99.9% 01 Dec 2014 01 Mar 2015 10-Q 30 Mar 2016
Q4 2014 -$9.52M $350M -$11M -3.05% 30 Aug 2014 30 Nov 2014 10-Q 07 Jan 2016
Q3 2014 $1.48M $398K +$120K +43.2% 02 Jun 2014 31 Aug 2014 10-Q 01 Oct 2015
Q2 2014 $1.36M -$713M -$713M -127408% 24 Feb 2014 25 May 2014 10-K 01 Aug 2016
Q1 2014 $715M $353M +$353M +75978% 25 Nov 2013 23 Feb 2014 10-Q 02 Apr 2015
Q4 2013 $362M $361M +$361M +111665% 26 Aug 2013 24 Nov 2013 10-Q 09 Jan 2015
Q3 2013 $1.63M $278K -$70K -20.1% 27 May 2013 25 Aug 2013 10-Q 08 Oct 2014
Q2 2013 $1.7M $560K +$884M 25 Feb 2013 26 May 2013 10-K 31 Jul 2015
Q1 2013 -$882M $464K +$35K +8.16% 26 Nov 2012 24 Feb 2013 10-Q 28 Mar 2014
Q4 2012 -$882M $323K -$444M -99.9% 27 Aug 2012 25 Nov 2012 10-Q 03 Jan 2014
Q3 2012 -$439M $348K -$441M -99.9% 28 May 2012 26 Aug 2012 10-Q 26 Sep 2013
Q2 2012 $1.87M -$884M 27 Feb 2012 27 May 2012 10-K 01 Aug 2014
Q1 2012 $429K 28 Nov 2011 26 Feb 2012 10-Q 04 Apr 2013
Q4 2011 $444M 29 Aug 2011 27 Nov 2011 10-Q 04 Jan 2013
Q3 2011 $441M 28 May 2011 28 Aug 2011 10-Q/A 02 Jan 2013

LIFECORE BIOMEDICAL, INC. \DE\ Annual Share-based Payment Arrangement, Expense (USD)

Period Value YoY Chg Change % Start Date End Date Report Filed
2024 $10.2M +$3.96M +63.8% 27 May 2024 25 May 2025 10-K 07 Aug 2025
2023 $6.2M +$2.59M +71.7% 29 May 2023 26 May 2024 10-K 07 Aug 2025
2022 $3.61M +$1M +38.5% 30 May 2022 28 May 2023 10-K 26 Aug 2024
2021 $2.61M -$752K -22.4% 31 May 2021 29 May 2022 10-K 26 Aug 2024
2020 $3.36M +$941K +38.9% 01 Jun 2020 30 May 2021 10-K 20 Mar 2024
2019 $2.42M -$1.14M -32.1% 27 May 2019 31 May 2020 10-K/A 16 Mar 2023
2018 $3.56M -$843K -19.1% 28 May 2018 26 May 2019 10-K 29 Jul 2021
2017 $4.4M +$439K +11.1% 29 May 2017 27 May 2018 10-K 14 Aug 2020
2016 $3.96M +$499K +14.4% 30 May 2016 28 May 2017 10-K 01 Aug 2019
2015 $3.47M +$1.89M +120% 01 Jun 2015 29 May 2016 10-K 09 Aug 2018
2014 $1.58M +$221K +16.3% 26 May 2014 31 May 2015 10-K/A 15 Mar 2018
2013 $1.36M -$339K -20% 27 May 2013 25 May 2014 10-K 01 Aug 2016
2012 $1.7M -$177K -9.46% 28 May 2012 26 May 2013 10-K 31 Jul 2015
2011 $1.87M 30 May 2011 27 May 2012 10-K 01 Aug 2014
* An asterisk sign (*) next to the value indicates that the value is likely invalid.